![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Resistance Analysis of HCV Genotype 1 Patients Treated With Sofosbuvir in Combination With Ledipasvir or the NS5B Non-Nucleoside Inhibitor GS-9669: The ELECTRON Study
|
|
|
Reported by Jules Levin
EASL 2014 April 9-13 London, UK
Evguenia Svarovskaia,1 Ross Martin,1 Viktoria Gontcharova,1 Robert H. Hyland,1 Edward J. Gane,2 Catherine A. Stedman,3 William T. Symonds,1 Michael D. Miller,1 Hongmei Mo1
1Gilead Sciences, Inc., Foster City, California, USA; 2Auckland City Hospital, Grafton, Auckland, New Zealand; 3Christchurch Hospital and University of Otago, Christchurch, New Zealand
![EASL1.gif](../images/042114/042114-10/EASL1.gif)
![EASL2.gif](../images/042114/042114-10/EASL2.gif)
![EASL3.gif](../images/042114/042114-10/EASL3.gif)
![EASL4.gif](../images/042114/042114-10/EASL4.gif)
![EASL5.gif](../images/042114/042114-10/EASL5.gif)
![EASL6.gif](../images/042114/042114-10/EASL6.gif)
![EASL7.gif](../images/042114/042114-10/EASL7.gif)
![EASL8.gif](../images/042114/042114-10/EASL8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|